改良女性自我形象评价量表(MBIS)、尿失禁生活质量问卷(I-QOL)、子宫肌瘤症状及健康相关生活质量问卷(UFS-QOL)中文版本研制与中国人群验证
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
研究背景
     盆腔器官脱垂(pelvic organ prolapse, POP)、尿失禁(urinary incontinence,UI)及子宫平滑肌瘤(uterine fibroids, UF)是女性生殖系统的常见的非致命性疾病。其中尿失禁从上世纪90年代起开始被认为是影响人类的五大疾病之一。上述三种疾病不仅给患者的生理、心理及性生活等方面带来诸多影响,而且还造成了社会的巨大经济支出,严重影响女性患者的健康相关生活质量(health-related quality of life, HRQL)。研究显示对于POP、UI及UF,临床客观检查结果并不完全与患者主观感受一致,仅依靠临床妇科查体与各项辅助检查并不能准确地反应患者病情的严重程度和评价治疗效果。
     近几年使用问卷对患者HRQL评估日益普及,患者报告结果(patient reported outcomes, PRO)是POP、UI及UF诊断和疗效评价中非常重要的工具。国际上评价POP、UI及UF患者生活质量的问卷主要为英文问卷,非英文母语的问卷不能简单翻译后即被应用,应按照"WHO-QOL跨文化生活质量研究问卷翻译法”译制并经统计学方法验证后方可使用。本院妇产科已有前期研究,完成对盆腔器官脱垂与尿失禁性功能问卷简版(PISQ-12).盆底功能影响问卷简版(PFIQ-7)及尿失禁影响问卷简版(IIQ-7)的译制和验证。
     国际上常用的改良女性自我形象评价量表(The Modified Body Self-Image Scale,MBIS)、国际尿控协会ICS推荐的尿失禁生活质量问卷(Incontinence Quality of Life Questionnaire,I-QOL)、作为妇科良性肿瘤常见病的子宫肌瘤症状及健康相关生活质量问卷(The Uterine Fibroid Symptom and Health-Related Quality of Life, UFS-HRQL)问卷在中国尚未经过验证,故影响临床的准确使用,是亟待解决的临床重要问题。
     改良女性自我形象评价量表(MBIS)简体中文版研制与验证
     目的
     本研究引进国际上常用的改良女性自我形象评价量表(MBIS),对其进行中文版本的研制,并评价其在POP患者中应用的信度和效度。
     方法
     1.在北京协和医院妇产科门诊随机选取符合纳入标准的症状性POP患者。
     2.以"WHO-QOL跨文化生活质量研究问卷翻译法”为标准对MBIS进行中文版本研制。
     3.对研制的简体中文版MBIS进行中国人群的信度效度检验。
     结果
     1.52例符合纳入标准的POP患者参与改良女性自我形象评价量表MBIS的验证。
     2.简体中文版MBIS量表总的Cranach's α系数为0.926,量表的内部一致性较好。
     3.简体中文版MBIS两次调查结果各题目得分之间ICC值为0.554-0.963(P<0.01),重测信度良好,Wilcoxon符号秩检验显示两次调查中所有题目得分间的差异无统计学意义(P>0.05)。
     4.因子分析结果显示简体中文版MBIS提取出的因子成分为1与制作者设计相符合,量表具有极高的结构效度。
     5.简体中文版MBIS与中文版SF-12得分在0.01水平(双侧)上显著相关,Spearman相关系数r1为-0.390,相关程度普通。说明MBIS得分越高,患者生活质量越低。与简体中文版PISQ-12得分在0.01水平(双侧)上显著相关,Spearman相关系数r2为-0.709,相关程度高。说明MBIS得分越高,患者性功能评价越低。
     尿失禁生活质量问卷(I-QOL)简体中文版研制与验证
     目的
     本研究引进国际尿控协会ICS推荐的尿失禁生活质量问卷(I-QOL),对其进行中文版本的研制,并评价其在UI患者中应用的信度和效度。
     方法
     1.在北京协和医院妇产科门诊随机选取符合纳入标准的UI患者。
     2.以"WHO-QOL跨文化生活质量研究问卷翻译法”为标准对I-QOL进行中文版本研制。
     3.对研制的简体中文版I-QOL进行中国人群的信度效度检验。
     结果
     1.148例符合纳入标准的UI患者参与尿失禁生活质量问卷I-QOL验证,其中SUI患者47人,UUI患者51人,MUI患者50人。
     2.简体中文版I-QOL量表总的Cranach's a系数为0.963,量表的内部一致性较好。
     3.两次调查简体中文版I-QOL量表结果各题目得分之间ICC值为0.74-0.96(P<0.01),重测信度良好,Wilcoxon符号秩检验显示两次调查中所有题目得分间的差异无统计学意义(P>0.05)。
     4.因子分析结果显示简体中文版I-QOL提取出的因子成分为3与制作者设计相符合,量表具有极高的结构效度。
     5.简体中文版I-QOL与中文版SF-12得分在0.01水平(双侧)上显著相关,Spearman相关系数r1为0.829,相关程度高。说明I-QOL得分越高,患者生活质量越高。I-QOL与1h尿垫结果在0.01水平(双侧)上显著相关,Spearman相关系数r2为-0.312,相关程度普通。说明1h尿垫结果越高,I-QOL得分越低,患者生活质量越差,与原量表设计相吻合。
     子宫肌瘤症状及健康相关生活质量问卷(UFS-HRQL)简体中文版研制与验证目的
     本研究引进子宫肌瘤症状及健康相关生活质量问卷(UFS-HRQL),对其进行中文版本的研制,并评价其在症状性UF患者中应用的信度和效度。
     方法
     1.在北京协和医院妇产科门诊随机选取符合纳入标准的症状性UF患者。
     2.以"WHO-QOL跨文化生活质量研究问卷翻译法”为标准对UFS-HRQL进行中文版本研制。
     3.对研制的简体中文版UFS-HRQL进行中国人群的信度效度检验。
     结果
     1.190例符合纳入标准的症状性UF患者参与简体中文版UFS-HRQL验证,其中拟HIFU治疗的患者18人,拟子宫肌瘤剔除术治疗125人;拟子宫切除术治疗47人。
     2.简体中文版UFS-HRQL症状亚量表UFS8Cranach's a系数为0.912;生活质量亚量表HRQL Cranach's a系数0.976,说明量表的内部一致性较好。
     3. UFS8亚量表两次调查结果各题目得分之间ICC值为0.572-0.951(P<0.01), HRQL亚量表该值为:0.628-0.931,(P<0.01),说明量表重测信度良好。Wilcoxon符号秩检验显示两次调查中所有题目得分间的差异无统计学意义(P>0.05)
     4.因子分析结果显示UFS-HRQL生活质量亚量表提取出的因子成分为6,与制作者设计相符合,量表具有极高的结构效度。
     5. UFS8亚量表与中文版SF-12得分在0.01水平(双侧)上显著相关,Spearman相关系数r1为-0.813,相关程度高。说明UFS8亚量表得分越高,患者生活质量越差。HRQL亚量表与中文版SF-12得分在0.01水平(双侧)上显著相关,Spearman相关系数r2为0.620,相关程度显著,说明HRQL亚量表得分越高,患者生活质量越高。
     结论
     研究结果表明,我们研制的MBIS、I-QOL及UFS-HRQL中文版本在中国人群中具有较高的信度和效度,可以作为评价相关疾病生活质量的专用量表。
Pelvic organ prolapse (POP), urinary incontinence (UI) and Uterine Fibroid(UF) are common non-fatal disease of the female reproductive system.Treatment for such diseases, in addition to anatomic reconstruction, the more important is to improve patient's quality of life. Questionnaire as an assessment of patient-oriented approach is widely used in the POP, UI and UF clinical treatment and research. Many questionnaires currently used in pelvic floor and uterine fibroid research were validated in population of middle class Americans in American English. Most of them were validated in the target languages. As the conditions of domestic clinicians, most of the clinical used questionnaires were self-translated; this lacks psychometric cross-language translation and validation. It impedes the domestic clinical use of questionnaires and needs to be resolved.
     The validation of the Chinese version of the Modified Body Self-Image Scale (MBIS)
     Objective
     To evaluate the reliability and validity of the Chinese version of the Modified Body Self-Image Scale (MBIS) in patients with POP.
     Methods
     1. The Original English MBIS was translated into Chinese and linguistically validated following the Cross-cultural adaptation of health-related quality of life measures.
     2. Patients recruited randomly from PUMCH clinics were scheduled for two visits with2weeks apart, and they were surveyed through the Chinese version of the MBIS,SF-12and PISQ-12.
     3. Evaluate the reliability and validity of the Chinese version of the Modified Body Self-Image Scale.
     Results
     A total of52POPpatients who met the criteria participated the study,All the subscales of MBIS showed high levels of internal consistency(Cranach's α=0.926);moderate to excellent test-retest reliability(ICC:0.554-0.963,P<0.01)and acceptable construct validity. The MBIS and SF-12scores were negatively correlated.(r=-0.390;P<0.001). The MBIS scores and PISQ-12scores were negatively correlated.(r=-0.709; P<0.001).
     The validation of the Chinese version of Incontinence Quality of Life Questionnaire (I-QOL)
     Objective
     To evaluate the reliability and validity of the Chinese version of the Incontinence Quality of Life Questionnaire (I-QOL) in patients with UI.
     Methods
     1. The Original English I-QOL was translated into Chinese and linguistically validated following the Cross-cultural adaptation of health-related quality of life measures.
     2. Patients recruited randomly from PUMCH clinics were scheduled for two visits with2weeks apart,and they were surveyed through the Chinese version of the I-QOL,SF-12.All the patients have the1h pad test.
     3. Evaluate the reliability and validity of the Chinese version of the I-QOL.
     Results
     A total of148POP patients who met the criteria participated the study,within SUI47,UUI51, MUI50.All the subscales of I-QOL showed high levels of internal consistency(Cranach's α=0.963); excellent test-retest reliability(ICC:0.74-0.96,P<0.01)and acceptable construct validity.The I-QOL and SF-12scores were positively correlated.(r=0.829;P<0.001). The I-QOLscores and1h pad results were negatively correlated.(r=-0.312; P<0.001).
     The validation of the Chinese version of The Uterine Fibroid Symptom and Health-Related Quality of Life (UFS-HRQL)
     Objective
     To evaluate the reliability and validity of the Chinese version of the The Uterine Fibroid Symptom and Health-Related Quality of Life, UFS-HRQL in patients with UF.
     Methods
     1. The Original English UFS-HRQL was translated into Chinese and linguistically validated following the Cross-cultural adaptation of health-related quality of life measures.
     2. Patients recruited randomly from PUMCH clinics were scheduled for two visits with2weeks apart,and they were surveyed through the Chinese version of the UFS-HRQL and SF-12
     3. Evaluate the reliability and validity of the Chinese version of the UFS-HRQL.
     Results
     A total of190UF patients who met the criteria participated the study The Chinese UFS-HRQL had a high internal consistency (Cronbach's alpha,0.912-0.976and high test-retest reliability (ICC coefficient,0.572-0.951; P<0.001).The symptom severity scores and SF-12scores were negatively correlated.(r=-0.813;P<0.001). The HRQL scores and SF-12scores were positively correlated.(r=0.620; P<0.001).The factor analysis showed good construct validity.
     Conclusion
     Psychometric testing supports the reliability and validity of the Chinese version of the MBIS, I-QOL and UFS-HRQL as an diease-specific measure of HRQOL.
引文
[1]Hagen S, Stark D, Maher C, et al (2006). Conservative management of pelvic organ prolapse in women. Cochrane Database of Systematic Reviews Issue 4. Art.
    [2]Maher C, Baessler K, Glazener CM, et al (2007).Surgical management of pelvic organ prolapse in women.Cochrane Database of Systematic Reviews Issue 3.
    [3]Adams EJ, Thomson A, Maher C, et al (2004) Mechanical devices for pelvic organ prolapse in women. Cochrane Database of Systematic Reviews Issue 2.
    [4]Lowenstein L, Gamble T, Sanses TV, van Raalte H, Carberry C, Jakus S, Kambiss S, McAchran S, Pham T, Aschkenazi S, Hoskey K, Kenton K. Fellow's Pelvic Research Network. J Sex Med 2009;6:2286-91.
    [5]Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 2001;185:1388-95.
    [6]Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol 2006;194:1455-61.
    [7]Koch P, Mansfield P, Thurau D, et al. Feeling frumpy:The relationship between body image and sexual response changes in midlife women. J Sex Res 2005;42:215-23.
    [8]Sanchez D, Kiefer A. Body concerns in and out of the bedroom:Implications for sexual pleasure and problems. Arch Sex Behav 2007;36:808-20.
    [9]Berman L, Berman J, Miles M, et al. Genital self-image as a component of sexual health: Relationship between genital self-image, female sexual function, and quality of life measures. J Sex Marital Ther 2003;29:11-21.
    [10]Liao, L.,& Creighton, S. Requests for cosmetic genitoplasty:How should healthcare providers respond? British Medical Journal,2007,334,1090-1092
    [11]Ruth Zielinski,Janis Miller, Lisa Kane Low,et al. The Relationship Between Pelvic Organ Prolapse, Genital Body Image, and Sexual Health. Neurourology and Urodynamics,2012,31:1145-1148
    [12]Lior Lowenstein, Tondalaya Gamble, Tatiana V, et al. Changes in Sexual Function after Treatment for Prolapse Are Related to the Improvement in Body Image Perception. Sex Med 2010;7:1023-1028
    [13]Patel MS, Mellen C, O'Sullivan DM, et al. Pessary use and impact on quality of life and body image. Female Pelvic Med Reconstr Surg.2011,17:298-301.
    [14]Segedi LM, Ilic KP, Curcic A, et al. Quality of life in women with pelvic floor dysfunction. Vojnosanit Pregl.2011 Nov;68(11):940-7.
    [15]Hopwood P, Fletcher I, Lee A, Al Ghazal S. A body image scale for use with cancer patients. Eur J Cancer 2001;37:189-97.
    [16]Baxter NN, Goodwin PJ, McLeod RS, et al. Reliability and validity of the body image after breast cancer questionnaire. Breast J.2006 May-Jun;12(3):221-32.
    [17]Homes JM, Lytle LA, Gross CR, Ahmed RL,Troxel AB, Schmitz KH. The body image and relationships scale:development and validation of a measure of body image in female breastcancer survivors. J Clin Oncol.2008 Mar 10;26(8):1269-74
    [18]Garry R, Fountain J, Mason S, Hawe J, Napp V, Abbott J, et al. The eVALuate study:two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ 2004;328:129.
    [19]Cindy LKL, Eileen YYT, Barbara G Is the standard SF-12 Health Survey valid and equivalent for a Chinese population? Qual Life Res 2005; 14:539-547
    [20]Zhu L, Yu S, Xu T, Yang X, Lu Y, Lang J. Validation of the Chinese version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire short form (PISQ-12).Int J Gynaecol Obstet.2012 Feb; 116(2):117-9.
    [21]Guillemin F.Cross-cultural adaptation and validation of health status measures.Stand J Rheumatol,1995,24:61-63.
    [22]Burrows LJ, Meyn LA, Walters MD,Weber AM. Pelvic symptoms in women with pelvic organ prolapse. Obstet Gynecol 2004; 104:982-8.
    [1]Samuelsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women aged 20-59 years. Prevalence, well-being and wish for treatment. Acta Obstet Gynecol Scand.1997 Jan; 76(1):74-80.
    [2]Abrams P et al:The standardisation of terminology in lower urinary tract function:Report from the standardisation sub-committee of the International Continence Society. Urology 2003;61:37.
    [3]Diokno A et al:Prevention of urinary incontinence by behavioral modification program:A randomized, controlled trial among older women in the community. J Urol 2004; 171:1165.
    [4]Grimby A, Milsom I, Molander U, Wiklund I, Ekelund P. The influence of urinary incontinence on the quality of life of elderly women. Age Ageing.1993 Mar;22(2):82-9.
    [5]Diokno AC et al, OPERA Study Group:Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder:Results of the OPERA trial. Mayo Clin Proc 2003; 78:687
    [6]朱兰,郎景和,王宏,韩少梅,刘春燕.北京地区成年女性尿失禁的流行病学研究.中华医学杂志.2006,86(11);728-731
    [7]Sun MJ, Chen GD, Chang SY,ct at Prevalence Of lower urinary tract symptoms during pregnancy in Taiwan.J Formes Med Assoc.2005;104:185-189.
    [8]LaSala CA, Kuchel GA. Evaluation and management of urinary incontinence in elderly women. Conn Med.2003 Sep; 67(8):491-5.
    [9]Barber MD, Walter MD, Cundiff GW et al. Responsiveness of the Pelvic Floor Distress Inventory(PFD1)and Pelvie Floor impact Questionnaire(PF1Q)in women undergoing vaginal surgery and pessary tretment for pelvic organ prolapse.Am J Obstet Gynecol.2006;194:1492-1498.
    [10]Doward.L C, S.P.McKenna.Defining patient-reported outcomes.Value Heahth.2004,7:S4-S8.
    [11]Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 2003; 189:98-101
    [12]Bradley CS, Rovner ES, Morgan MA, Berlin M, Novi JM, Shea JA et al.A new questionnaire for urinary incontinence diagnosis in women:development and testing. Am J Obstet Gynecol, 2005; 192:66-73
    [13]Ohsj K. Is a generic quality of life instrument helpful for evaluating women with urinary incontinence? Qual life Res.2006; 15:493-501
    [14]Bushnell DM, Martin ML, Summers KH, Svihra J, Lionis C, Patrick DL. Quality of life of women with urinary incontinence:Cross-cultural performance of 15 language versions of the I-QOL. Qual Life Res.2005 Oct;14(8):1901-13.
    [15]Nojomi M, Baharvand P, Moradi Lakeh M, Patrick DL. Incontinence quality of life questionnaire (I-QOL):translation and validation study of the Iranian version. Int Urogynecol J Pelvic Floor Dysfunct.2009 May; 20(5):575-9.
    [16]Cindy LKL, Eileen YYT, Barbara G. Is the standard SF-12 Health Survey valid and equivalent for a Chinese population? Qual Life Res 2005; 14:539-547
    [17]Guillemin F.Cross-cultural adaptation and validation of health status measures.Stand J Rheumatol,1995,24:61-63.
    [18]Petros PEP. The female pelvic floor. Germany:Springer Medsizin Verlng Heidelberg,2004; 1-13.
    [19]宋岩峰.女性尿失禁流行病学研究和治疗进展.中华妇产科杂志,2004,39(8);563-565
    [20]Carolina Chaves Cunha Souza, Andrea Moura Rodrigues, Cristina Eustaquia Ferreira. Portuguese validation of the Urinary Incontinence-Specific Quality-of-Life Instrument:I-QOL. Int Urogynecol J (2009) 20:1183-1189
    [1]Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol 2005;48:312-324.
    [2]Istre O. Management of symptomatic fibroids:conservative surgical treatment modalities other than abdominal or laparoscopic myomectomy. Best Pract Res Clin Obstet Gynaecol 2008;22:735-747.
    [3]Spies JB, Coyne K, Guaou Guaou N, Boyle D, Skyrnarz-Murphy K, Gonzalves SM. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002;99:290-300.
    [4]Spies JB, Myers ER, Worthington-Kirsch R, Mulgund J, Goodwin S,Mauro M; FIBROID Registry Investigators. The FIBROID Registry:Symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 2005; 106:1309-1318.
    [5]Harding G, Coyne K, Barrett RJ, Pixton GC. Modified visual analog scale symptom-intensity and overall-bother measures for the assessment of symptoms in studies of pharmacologic stress agents. Clin Ther 2009;31(4):889-901
    [6]Coyne KS, Margolis MK, Murphy J, Spies J. Validation of the UFS-QOL-hysterectomy questionnaire:modifying an existing measure for comparative effectiveness research. Value Health 2012;15(5):674-679
    [7]Cindy LKL, Eileen YYT, Barbara G. Is the standard SF-12 Health Survey valid and equivalent for a Chinese population? Qual Life Res 2005; 14:539-547
    [7]Guillemin F.Cross-cultural adaptation and validation of health status measures.Stand J Rheumatol,1995,24:61-63.
    [7]Lam CL, Tse EY, Gandek B. Is the standard SF-12 health survey valid and equivalent for a Chinese population? Qual Life Res 2005;14:539-547.
    [8]Bruns H, Kratschmer K, Hinz U, Brechtel A, Keller M, Buchler MW, Schemmer P. Quality of life after curative liver resection:a single center analysis. World J Gastroenterol 2010;16:2388-2395.
    [9]Wong SY, Mak WW, Cheung EY, Ling CY, Lui WW, Tang WK, Wong RL, Lo HH, Mercer S, Ma HS. A randomized, controlled clinical trial:the effect of mindfulness-based cognitive therapy on generalized anxiety disorder among Chinese community patients:protocol for a randomized trial. BMC Psychiatry 2011; 11:187.
    [10]Cronbach LF. Coefficient alpha and the internal structure of tests. Psychometricka 1951; 16:297-334.
    [11]Lohr K.N. Assessing health status and quality-of-life instruments:attributes and review criteria. Qual Life Res 2002; 11:193-205.
    [12]Wu XM. The application of factor analysis in reliability and validity assessment. Journal of Chronic Disease Prevention and Control in China 1998;6:28-31.
    [13]Harding G, Coyne KS, Thompson CL, Spies JB.The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL). Health Qual Life Outcomes 2008;6:99.
    [14]Coyne KS, Margolis MK, Bradley LD, Guido R, Maxwell GL, Spies JB. Further validation of the uterine fibroid symptom and quality-of-life questionnaire. Value Health 2012;15:135-142.
    [15]Guillemin F. Cross-cultural adaptation and validation of health status measures. Scand J Rheumatol 1995;24:61-63.
    [16]Janssen CA, Scholten PC, Heintz AP. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss. Obstet Gynecol 1995;85:977-982.
    [1]Nygaard I, Bradley C, Brandt D (2004) Pelvic organ prolapse in older women:prevalence and risk factors. Obstet Gynecol 104:489-97
    [2]Rogers RG, Villarreal A, Kammerer-Doak D, Qualls C (2001) Sexual function in women with and without urinary incontinence and/or pelvic organ prolapse. Int Urogynecol J 12:361-365
    [3]Pauls RN, Silva WA, Rooney CM, Siddighi S, Kleeman SD, Dryfhout V, Karram MM (2008) Sexual function after vaginal surgery for pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 97:622e1-622.e7
    [4]张迎辉,鲁永鲜.。盆底功能障碍研究中的调查问卷。中华妇产科杂志。2009:vol44,No12
    [5]Creti L, Fichten CS, Libman E, Amsel R, Brender W (1988) Female sexual functioning:a global score for Nowinski and Lopiccolo's sexual history form. Paper presented at the convention of Canadian Psychological Association, Montreal, Quebec
    [6]Rosen RC, Brown C, Heiman J, Leiblum S, Meston CM, Sabsigh R, Ferguson D, D'Agostino R (2000) The Female Sexual Function Index (FSFI):a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191-208
    [7]Wiegal M, Meston C, Rosen R (2005) The Female Sexual Function Index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31:1-20
    [8]Kelleher CJ, Cardozo LD, Khuller V, Salvatore S (1997) A new questionnaire to assess the quality of life of urinary incontinent women. Br J Obstet Gynecol 104:1374-1379
    [9]Wyman JF, Harkins SW, Choi SC, Taylor JR, Fantl JA (1987).Psychosocial impact of urinary incontinence in women. Obstet Gynecol 70:378-381
    [10]Rogers RG, Kammerer-Doak DN, Villarreal A, Coates K, Qualls C (2001) A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse. Am J Obstet Gynecol 184:552-558
    [11]Rogers RG, Coates KW, Kammerer-Doak D, Khalsa S, Qualls C. A short form of the Pelvic Organ Prolapse/Urinary IncontinenceSexual Questionnaire (PISQ-12). Int Urogynecol J 2003; 14: 164-168
    [12]Romero AA, Hardart A, Kobak W, Qualls C, Rogers R. Validation of a Spanish Version of the Pelvic Organ Prolapse Incontinence Sexual Questionnaire. Obstet Gynecol 2003; 102:1000-1005
    [13]Fatton B, Letouzey V, Lagrange E, Mares P etc. Validation of a French version of the short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12). J Gynecol Obstet Biol Reprod (Paris) 2009 Dec; 38(8):662-667
    [14]Cetin C, Pinar S, Nazan K, Ali S, Cem C, Ates K. Validation of the short form of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12) in a Turkish population. Euro J Obstet Gynecol Repro Bio 146 2009:104-107
    [15]Zhu L, Yu S, Xu T, Yang X, Lu Y, Lang J. Validation of the Chinese version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire short form (PISQ-12).Int J Gynaecol Obstet.2012 Feb; 116(2):117-9.
    [16]李俊,刘朝杰,李宁秀,等。生命质量评价量表SF-36中国量化标准研究。华西医科大学学报,2001,32:36-38.
    [17]Cindy LKL, Eileen YYT, Barbara G. Is the standard SF-12 Health Survey valid and equivalent for a Chinese population? Qual Life Res 2005; 14:539-547
    [18]Rabin R,de Charro F.EQ-5D:a measure of health status from the EumQol Group,Ann Med,2001,33:337-343.
    [19]Barber MD, Kuchibhatla MN, Pieper CF, Bump RC. Psychometric evaluation of 2 comprehensive condition-specific quality of life instruments for women with pelvic floor disorders. Am J Obstet Gynecol 2001; 185:1338-1395.
    [20]Zhu L, Yu S, Xu T, Yang X, Lu Y, Li B, Lang J. Chinese validation of the Pelvic Floor Impact Questionnaire Short Form. Menopause.2011 Sep; 18(9):1030-3.
    [21]Reese PR, Pleil AM, Okano GJ, et al. Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder. Qual Life Res,2003,12:427-442.
    [22]Woodmanl PJ, Miskol CA, Fischer JR. The Use of Short-Form Quality of Life Questionnaires to Measure the Impact of Imipramine on Women with Urge Incontinence. Int Urogynecol J 2001;12:312-316